BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16675650)

  • 1. Toxicology of oral antidiabetic medications.
    Spiller HA; Sawyer TS
    Am J Health Syst Pharm; 2006 May; 63(10):929-38. PubMed ID: 16675650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of antidiabetic medications in overdose.
    Spiller HA
    Drug Saf; 1998 Nov; 19(5):411-24. PubMed ID: 9825953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Fisman EZ; Tenenbaum A; Motro M; Adler Y
    Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ; Ferner RE; Bailey CJ
    Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihyperglycaemic agents. Drug interactions of clinical importance.
    Scheen AJ; Lefèbvre PJ
    Drug Saf; 1995 Jan; 12(1):32-45. PubMed ID: 7741982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and other antidiabetic agents in renal failure patients.
    Lalau JD; Arnouts P; Sharif A; De Broe ME
    Kidney Int; 2015 Feb; 87(2):308-22. PubMed ID: 24599253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antidiabetic agents. A guide to selection.
    Scheen AJ; Lefèbvre PJ
    Drugs; 1998 Feb; 55(2):225-36. PubMed ID: 9506242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selection of oral antidiabetic drugs].
    Iwamoto Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():428-32. PubMed ID: 15779417
    [No Abstract]   [Full Text] [Related]  

  • 13. A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country.
    Zaghloul N; Awaisu A; Mahfouz A; Alyafei S; Elewa H
    Int J Clin Pharm; 2022 Dec; 44(6):1342-1350. PubMed ID: 36169802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of type 2 diabetes mellitus: pharmacologic intervention.
    McCormick M; Quinn L
    J Cardiovasc Nurs; 2002 Jan; 16(2):55-67. PubMed ID: 11800068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antihyperglycemic therapy for type 2 diabetes mellitus.
    Cheng AY; Fantus IG
    CMAJ; 2005 Jan; 172(2):213-26. PubMed ID: 15655244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral antihyperglycemic treatment options for type 2 diabetes mellitus.
    Brietzke SA
    Med Clin North Am; 2015 Jan; 99(1):87-106. PubMed ID: 25456645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current and future aspects of oral antidiabetic agents in type 2 diabetes].
    Rybka J
    Vnitr Lek; 2001 May; 47(5):285-90. PubMed ID: 11395869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral agents in the management of type 2 diabetes mellitus.
    Luna B; Feinglos MN
    Am Fam Physician; 2001 May; 63(9):1747-56. PubMed ID: 11352285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
    Fisman EZ; Motro M; Tenenbaum A
    Adv Cardiol; 2008; 45():154-170. PubMed ID: 18230961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
    Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
    Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.